M. Akhavanpoor

发表

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation

C. Gleissner, H. Katus, L. Frankenstein, 2016, Drug design, development and therapy.

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

C. Gleissner, H. Katus, T. Dengler, 2014, Drug design, development and therapy.

Systematic RNA-interference in primary human monocyte-derived macrophages: A high-throughput platform to study foam cell formation

H. Erfle, C. Gleissner, C. Weber, 2018, Scientific Reports.

Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease

C. Gleissner, H. Katus, S. Buss, 2014, Clinical Research in Cardiology.

Fully digital data processing during cardiovascular implantable electronic device follow-up in a high-volume tertiary center

L. Uhlmann, H. Katus, Dierk Thomas, 2017, European Journal of Medical Research.

High‐sensitive Troponin T measurements early after heart transplantation predict short‐ and long‐term survival

C. Gleissner, H. Katus, E. Giannitsis, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.

C. Gleissner, N. Osman, P. Schnabel, 2016, JACC. Cardiovascular imaging.

A human ex vivo atherosclerotic plaque model to study lesion biology.

C. Gleissner, H. Katus, T. Dengler, 2014, Journal of visualized experiments : JoVE.

The impact of continuous erythropoietin receptor activators in patients after heart transplantation with multifactorial anemia with chronic kidney disease

C. Gleissner, H. Katus, L. Frankenstein, 2014 .

IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis

Kristina M. Little, C. Gleissner, T. Giese, 2014, The Journal of Immunology.

Atherosclerosis Involved in Advanced Murine and Human Monocyte / Macrophage Lineage and Is IL-17 A Influences Essential Functions of the

Kristina M. Little, C. Gleissner, T. Giese, 2014 .

Adventitial tertiary lymphoid organ classification in human atherosclerosis.

C. Gleissner, F. Lasitschka, H. Katus, 2018, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy

C. Gleissner, H. Katus, L. Frankenstein, 2014, Drug design, development and therapy.

Adventitial inflammation and its interaction with intimal atherosclerotic lesions

C. Gleissner, H. Katus, G. Korosoglou, 2014, Front. Physiol..

inhibition of B 7-1 ( cD 80 ) by rhuDex ® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

C. Gleissner, H. Katus, T. Dengler, 2014 .

Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart Transplanted Patient

C. Gleissner, M. Karck, F. Sedaghat-Hamedani, 2015, Case reports in transplantation.

Systematic RNA-interference in primary human monocyte-derived macrophages: A high-throughput platform to study foam cell formation

H. Erfle, C. Gleissner, C. Weber, 2018, Scientific Reports.

The Two Faces of Interleukin-17A in Atherosclerosis.

C. Gleissner, H. Katus, A. Doesch, 2016, Current drug targets.

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

C. Gleissner, F. Lasitschka, H. Katus, 2014, Drug design, development and therapy.

Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies

C. Gleissner, W. März, M. Kleber, 2022, Frontiers in Cardiovascular Medicine.

Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application

C. Gleissner, H. Katus, C. Erbel, 2014, Front. Physiol..

Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia

C. Gleissner, H. Katus, A. Doesch, 2016, Innate immunity.

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

C. Gleissner, H. Katus, P. Ehlermann, 2014, Drug design, development and therapy.

CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology

C. Gleissner, H. Katus, E. Giannitsis, 2015, PloS one.

Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability.

C. Gleissner, F. Lasitschka, H. Katus, 2015, International journal of cardiology.

Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.

C. Gleissner, M. Kleber, H. Katus, 2017, Atherosclerosis.

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation

C. Gleissner, H. Katus, L. Frankenstein, 2015, Drug design, development and therapy.

Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology.

C. Gleissner, H. Katus, E. Giannitsis, 2016, Atherosclerosis.